Portage Biotech Inc expected to post a loss of 27 cents a share - Earnings Preview

Alpha Compute

26/02/2024 15:07

* Portage Biotech Inc  PRTG.OQ   PRTG.O  is expected to show
no
change in quarterly revenue when it reports  results on February
28 (estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Portage Biotech Inc is
for a
loss of 27 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Hold".​
    * Wall Street's median 12-month price target for Portage
Biotech
Inc is $7.00​, above​ its last closing price of $0.58. ​​​

This summary was machine generated February 26 at 15:07 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)